Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Super/Mega Movers
Out & Under Performers
Advances & Declines
Only Buyers / Sellers
Value Toppers
Arbitrage Opportunity
New Highs / Lows
52 Week Highs / Lows
LifeTime Highs / Lows
Exchange Turnover
Historical Return
Exchange Holidays
Volume
Volume Toppers
Block Deals
Bulk Deals
Highest & Lowest Delivery
Delivery Shockers
Unusual Volume Up/Down
Exchange Volume
Analysis
5 Day's Up/Down
Rising VDP
Rising VD Fall in P
Price Shockers
Indian Indices
Profit Report
Income Report
Industry Performance
Market Turnover Scripwise
Sector Watch
Special Tools
Above Moving Avarage
Below Moving Avarage
Bullish Reversal
Gap Up
Gap Down
Higher Opening
Lower Opening
Stocks < Previous Highs
Stocks < Previous Low
  News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Stock News
Global News
  Corporate Action
BSE / NSE Announcements
Book Closures
Board Meetings
Bonus Issues
Dividend Details
Right Issues
Corporate Results
Delisted Shares
Split of Face Value
Change of Name
Mergers
Demergers
  Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Forex
  Company Profile
Company Details
Smart Quote
Share Prices
Company Background
Board Members
MF Holdings
Company News
Peer Companies News
Financials
Profit & Loss
Balance Sheet
Cash Flow
Financial Ratios
Share Holdings Pattern
Results
Quaterly
Quick Review
Company Reports
Director's Report
Derivatives
IPO
BSE Company News
Lupin Ltd.
BSE Code 500257
ISIN Demat INE326A01037
Book Value (Rs) 576.33
NSE Code LUPIN
Dividend Yield % 0.59
Market Cap(Rs Mn) 933012.45
TTM PE(x) 17.90
TTM EPS(Rs) 114.11
Face Value (Rs) 2  
Industry : Pharmaceuticals & Drugs
  
06-Sep-2025 USFDA concludes PAI at Lupin’s Aurangabad facility
06-Sep-2025 Lupin informs about disclosure
03-Sep-2025 Lupin gets USFDA’s nod for Risperidone injectable
29-Aug-2025 Lupin informs about updates
20-Aug-2025 Lupin launches Bosentan Tablets for Oral Suspensi...
20-Aug-2025 Lupin informs about press release
12-Aug-2025 Lupin partners with Sandoz Group AG
12-Aug-2025 Lupin rises on partnering with Sandoz Group AG
11-Aug-2025 Lupin launches Glucagon for Injection USP, 1mg/vi...
06-Aug-2025 Lupin reports 52% rise in Q1 consolidated net pro...
06-Aug-2025 Lupin informs about investor presentation
06-Aug-2025 Lupin declines despite reporting 52% rise in Q1 c...
01-Aug-2025 Clarification sought from Lupin Ltd
24-Jul-2025 Lupin gets USFDA’s nod for Liraglutide and Glucag...
24-Jul-2025 Lupin informs about press release
Page 1 of 6
Prev || Next
Disclaimer  |  Privacy Policy  |  Rules and Regulation  |  Terms Of Use     Copyright 2008-2009 IITGROUP
Designed | Developed & Content Powered By www.accord.com ACCORD FINTECH